SEC Form 4 · accession 0001209191-17-050211
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. Anthony Ware
Director
Period of report
Aug 22, 2017
Accepted (ET)
Aug 24, 2017 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $21.45 | Aug 22, 2017 | A | 28,571 | A | — | Aug 21, 2027 | Common Stock | 28,571 | 28,571 | D |
| Director Stock Option (right to buy)F2 | $21.45 | Aug 22, 2017 | A | 10,694 | A | — | Aug 21, 2027 | Common Stock | 10,694 | 10,694 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 36 equal monthly installments beginning on September 22, 2017, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
- F2The stock option vests and becomes fully exercisable on May 30, 2018.